FDA clears Siemens Artis portfolio with Optiq AI imaging chain
Siemens Healthineers has received FDA clearance for 6 systems in its Artis interventional imaging portfolio. All 6 systems feature the Optiq AI imaging chain, which analyzes and optimizes image data in real time.
Siemens Healthineers has received FDA clearance for 6 new systems in its Artis interventional imaging portfolio, according to the company.
The cleared portfolio includes the floor, biplane, ceiling, and pheno versions of the Artis vision platform, as well as floor configurations of the Artis icono.explore and Artis genio platforms.
Each system includes the company’s Optiq AI imaging chain, which uses AI to analyze and optimize image data in real time.
Optiq AI applies deep-learning-based noise reduction across 2D imaging modes, including fluoroscopy, acquisition, and digital subtraction angiography. Siemens Healthineers said the denoising is intended to provide consistent visualization during interventional procedures.
Kris McVey, head of angiography in the Advanced Therapies business at Siemens Healthineers North America, said “increased precision is of paramount importance” as more complex procedures move into interventional labs.
Advanced 3D applications in the portfolio include syngo DynaCT MORE, which is designed to reduce motion-related artifacts during intraprocedural 3D imaging. The portfolio also includes Touch UI tableside controls and standardized controls across systems.
The Artis vision systems are designed for high-speed, precise image-guided procedures. Artis icono.explore floor is intended for high-throughput departments, while Artis genio floor is positioned for broad interventional case mixes, according to Siemens Healthineers.
Optiq AI was introduced in late 2025 during RSNA in Chicago.
Company:Siemens Healthineers
Sources
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
SimonMed highlights role in large global X-ray AI study
The study analyzed 258,373 X-rays from 100 medical centers across 26 countries and evaluated the Rayvolve AI Suite across trauma, chest, measurement, and bone age use cases.
Neurophet names Lawrence Tanenbaum scientific advisor
The neuroradiologist and former RadNet CTO will advise the neuroimaging AI company as it seeks to strengthen clinical validation and U.S. market expansion.
CMR-CLIP AI model interprets cardiac MRI scans with high accuracy
The model was trained on more than 13,000 cardiac MRI studies and linked moving heart images with clinical radiology reports, according to the research team.
Flywheel integrates with AWS HealthImaging
The integration combines AWS HealthImaging’s cloud-based DICOM storage with Flywheel’s imaging data orchestration tools for clinical trials, research, and AI development.
GE HealthCare opens free HelloAI training program
The company is making the HelloAI Professional track available at no cost, adding more than 20 hours of on-demand healthcare AI education.
Siemens links coronary CT planning to cath-lab PCI guidance
The system combines Syngo.CT Coronary Cockpit and Syngo PCI Connect to transfer preprocessed coronary CT angiography data into the cath lab.
AZmed gets FDA clearance for expanded AZtrauma scope
The clearance expands AZtrauma beyond fracture detection to include joint effusions and dislocations on X-rays in adults and children ages 2 years and older.
HOPPR launches mammography vision-language model
The HOPPR EB 2D Mammo Narrative Model generates structured narrative output from 2D mammography images for breast imaging workflow applications.
DeepHealth secures AI clearances for neuro, prostate tools
The regulatory milestones cover Neuro Suite Brain Health and Brain Age, LumbarMR, and Prostate AI within DeepHealth’s clinical AI portfolio.
Philips introduces SmartIQ for Azurion coronary imaging
The coronary imaging technology adds an ultra-low-dose protocol for Philips’ Azurion image-guided therapy platform and is available in Europe and selected markets.
Azra AI, RevealDx partner on lung nodule AI
Azra AI will integrate RevealAI-Lung into its incidental findings and oncology workflow platform.
Accuro XV clearance gives Rivanna path into MSK ultrasound
Rivanna received FDA 510(k) clearance for Accuro XV, a diagnostic ultrasound system for musculoskeletal imaging. The company is also developing AI tools for bone visualization and fracture detection.